Aegerion Pharmaceuticals, Inc.

CIK 1338042 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aegerion Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 9, 2019SEC STAFF ACTION9999999997-19-006430
Aug 8, 2019T-3/A0001140361-19-014499
Jul 18, 2019T-30001140361-19-013140
Feb 14, 2017SC 13G/A0001421578-17-000007
Feb 14, 2017SC 13G/A0000919574-17-001806
Feb 8, 2017SC 13G/A0001319244-17-000021
Jan 31, 2017SC 13G/A0001123292-17-000280
Dec 12, 2016SC 13G/A0000315066-16-006472
Dec 9, 201615-12B0001104659-16-161507
Dec 8, 2016EFFECT9999999995-16-006409
Dec 5, 2016SC 13G/A0000891092-16-019320
Dec 1, 201640000919574-16-016972
Dec 1, 2016SC 13D/A0000919574-16-016968
Nov 30, 201640001104659-16-159822
Nov 30, 201640001104659-16-159830
Nov 30, 201640001104659-16-159827
Nov 30, 201640001104659-16-159832
Nov 30, 201640001104659-16-159823
Nov 30, 201640001104659-16-159829
Nov 30, 201640001104659-16-159826
Nov 30, 201640001104659-16-159821
Nov 30, 201640001104659-16-159824
Nov 30, 201640001104659-16-159834
Nov 30, 2016SC 13D/A0000899140-16-001707
Nov 30, 201640001104659-16-159825